🐦 推特Wall St EngineCodex · 实盘不做把握 8/10
北京时间·🕒 发布 18:15:20时区推断·⟳ 抓取 18:16:09·⚡ 决策 08-04 18:18:25 +2m16s·84.0 天前
沃特世二季度业绩小幅超预期并上调全年指引
本条是对沃特世同一二季度财报催化的社媒转述，系统已在10:03和10:05 UTC处理过同一事件。
📄 原文Wall St Engine@wallstengine↗ 原文
WATERS $WAT Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $1.65B (Est. $1.62B) 🟢 🔹 Adj. EPS: $3.05 (Est. $3.01) 🟢; +3% YoY 🔹 Org…
不做 沃特世（WAT.US）
同一具体财报催化已在10:03和10:05 UTC由系统处理过，当前推文只是重复转述且无新增事实，不再推交易卡。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-04 · 扩散 medium · price-in 风险 medium ↗
关键理由
- 本条是对沃特世同一二季度财报催化的社媒转述，系统已在10:03和10:05 UTC处理过同一事件。
- 财报本身为收入和EPS小幅超预期、全年指引小幅上调，但没有新增到足以覆盖重复推送的交易增量。
主要风险
- 若后续电话会披露超预期订单、整合协同或利润率拐点，应由新信号重新研判。
工具调用 · 历史记录,结果未知(3 种)
- search_processed_events · 结果未知
- stock_quote · 结果未知
- kb_search · 结果未知
原文全文
展开原文 · 1,213 字
WATERS $WAT Q2’26 EARNINGS HIGHLIGHTS
🔹 Revenue: $1.65B (Est. $1.62B) 🟢
🔹 Adj. EPS: $3.05 (Est. $3.01) 🟢; +3% YoY
🔹 Organic Revenue: $828M; +7% reported, +9% constant currency
🔹 BDS Revenue: $817M; +4% YoY
Q3 Guide:
🔹 Revenue: $1.7B-$1.8B (Est. $1.75B) 🟡
🔹 Adj. EPS: $3.95-$4.05 (Est. $3.99) 🟡; +16%-+19% YoY
Raises FY26 Guide:
🔹 Revenue: $6.4B-$6.5B (Est. $6.44B) 🟡
🔹 Adj. EPS: $14.45-$14.65 (Est. $14.51) 🟡; +10%-+12% YoY
Segment Net Revenue:
🔹 ASD: $669M; +7% YoY
🔹 WBD: $368M; +3% YoY
🔹 Diagnostic Solutions: $449M; +6% YoY
🔹 Clinical: $72M; +16% YoY
🔹 MSD: $87M; +6% YoY
Other Q2 Metrics:
🔹 Adjusted Operating Income: $411M (Est. $393M) 🟢
🔹 Adjusted Net Income: $301M (Est. $292M) 🟢
🔹 Adjusted Free Cash Flow: $202M (Est. $171M) 🟢
🔹 Adjusted Operating Margin: 25.0%; -410 bps YoY
Comments:
🔸 “we are raising every component of our full-year 2026 guidance … Waters is better positioned today than at any point in our recent history, with a broader portfolio, a larger installed base, and the clearest set of growth catalysts we have ever had.”
🔸 “Organic revenue grew 9% in constant currency, and our newly acquired businesses grew mid-single-digits in their first full quarter under Waters ownership.”
🔹 Revenue: $1.65B (Est. $1.62B) 🟢
🔹 Adj. EPS: $3.05 (Est. $3.01) 🟢; +3% YoY
🔹 Organic Revenue: $828M; +7% reported, +9% constant currency
🔹 BDS Revenue: $817M; +4% YoY
Q3 Guide:
🔹 Revenue: $1.7B-$1.8B (Est. $1.75B) 🟡
🔹 Adj. EPS: $3.95-$4.05 (Est. $3.99) 🟡; +16%-+19% YoY
Raises FY26 Guide:
🔹 Revenue: $6.4B-$6.5B (Est. $6.44B) 🟡
🔹 Adj. EPS: $14.45-$14.65 (Est. $14.51) 🟡; +10%-+12% YoY
Segment Net Revenue:
🔹 ASD: $669M; +7% YoY
🔹 WBD: $368M; +3% YoY
🔹 Diagnostic Solutions: $449M; +6% YoY
🔹 Clinical: $72M; +16% YoY
🔹 MSD: $87M; +6% YoY
Other Q2 Metrics:
🔹 Adjusted Operating Income: $411M (Est. $393M) 🟢
🔹 Adjusted Net Income: $301M (Est. $292M) 🟢
🔹 Adjusted Free Cash Flow: $202M (Est. $171M) 🟢
🔹 Adjusted Operating Margin: 25.0%; -410 bps YoY
Comments:
🔸 “we are raising every component of our full-year 2026 guidance … Waters is better positioned today than at any point in our recent history, with a broader portfolio, a larger installed base, and the clearest set of growth catalysts we have ever had.”
🔸 “Organic revenue grew 9% in constant currency, and our newly acquired businesses grew mid-single-digits in their first full quarter under Waters ownership.”
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。